Collection 

Retinal diseases

Submission status
Closed
Submission deadline

The retina of the eye contains photoreceptor cells that convert light into neuronal signals, which ultimately allow us to see. The mammalian retina has a very limited ability to regenerate, and damage to it severely impairs the ability to see, and therefore to interact with the environment. Retinal diseases are often related to age or conditions like diabetes and high blood pressure, though a small number of retinopathies are genetic. Independently of their origin, understanding the underlying mechanisms of these diseases, and enhancing treatment options, are interlinked.

This Collection aims to bring together the latest research which gives insight into clinical, genetic, or molecular mechanisms of all forms of retinal disease, or studies advancing their treatment.

Diagnosis eye diabetes.

Editors

  • Querques Giuseppe , 

    Querques Giuseppe

    University Vita-Salute, IRCCS San Raffaele Scientific Institute, Italy

  • Jeong Hun Kim  &

    Jeong Hun Kim

    Seoul National University College of Medicine, Korea

  • Xiaolai Zhou

    Xiaolai Zhou

    Sun Yat-sen University, China

Giuseppe Querques is an Associate Professor at University Vita-Salute, IRCCS San Raffaele Scientific Institute, Milan, Italy. His main topics are Medical Retina and ophthalmic surgery. He has contributed to more than 500 peer-reviewed articles and over 20 books and book chapters as Editor/Author published mainly in the areas of Medical Retina (age-related macular degeneration, retinal vascular diseases, hereditary retinal diseases, ophthalmic genetics). Dr Querques has been an Editorial Board Member for Scientific Reports since 2019.

 

 

Jeong Hun Kim is a Professor in Seoul National University College of Medicine and a clinician-scientist, who earned his MD in 1998 and Ph.D in 2006 from the Seoul National University. As a clinician (ophthalmology), he is a specialist in inherited retinal disease (IRD) as well as variable congenital and pediatric eye diseases including retinoblastoma and retinopathy of prematurity. Also, he has led a translational research laboratory of Fight against Angiogenesis-Related Blindness (FARB) Lab since 2009, where he has developed variable therapeutic candidates including small molecule, antibody, peptide, polymer, gene therapy, and genome editing targeting to retinopathy (AMD, diabetic retinopathy as well as IRD). Prof Kim has been an Editorial Board Member for Scientific Reports since 2017.

 

Xiaolai Zhou is a Professor of Ophthalmology and Principal Investigator of the Neuro-Ophthalmology Lab in the State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University (SYSU). His academic interests include 1) Disease mechanism, bio-markers, and treatment of neuromyelitis optica spectrum disorder (NMOSD); 2) Molecular mechanism of lysosomal dysfunction related-neurodegenerative diseases such as frontotemporal lobar degeneration (FTLD) and retinal degeneration caused by PGRN mutations; 3) Gene therapy for inherited retinal degeneration and optic nerve atrophy. Prof Zhou has been an Editorial Board Member for Scientific Reports since 2021.